Dr. E’s patient Kathy always kept her glucose levels very very low, as she had the misbelief that her A1c should be below 6. As a result, she had several dangerously low blood sugar episodes requiring emergency medical attention. What does Dr. E suggest?
read more →
Dr. Pettus and his research team at UCSD were recently awarded a $2M grant to study liver-targeted insulin in type 1 diabetes. Directing insulin to the liver may help restore normal liver physiology for people with type 1, leading to better glucose control and overall health.
read more →
Dr. E and Dr. P share some promising data that was presented at the recent American Diabetes Association conference regarding an islet cell infusion therapy for people with type 1 diabetes. If you have T1D with severe low blood sugar and impaired hypoglycemic awareness, you may be able to take part in the ongoing study.
read more →
Punk Rock Star Poli van Dam gets real about life with T1D both on and off the stage, and she shares how diabetes fuels her to help others.
read more →
After going through a difficult time adjusting to a type 1 diagnosis, physician Kimberly Jackson-Bekemeier discovered the power of a supportive wellness community that shifted her perspective. She was so inspired she became a life coach, and now helps others find joy while living with a chronic disease.
read more →
Danica Collins is a diabetes health and wellness coach, and she has lived with type 1 diabetes herself for over 17 years. Here she shares how and why she uses inhaled insulin Afrezza in her daily diabetes management.
read more →
TCOYD’s newest intern was diagnosed with type 1 diabetes at a young age, but his diagnosis ultimately gave him the foundation and passion to pursue a career in healthcare in order to help others living with the condition.
read more →Dr. E shares a case study from an MDI LADA patient, pointing out successes in his regimen along with recommendations for improvement.
read more →
History has just been made! The FDA recently approved a new treatment therapy called Tzield that works to prevent or delay the onset of type 1 diabetes. People at a high risk of developing type 1 can now delay its onset for years, giving them valuable time to learn about the condition and how to manage it safely.
read more →
Vertex Pharmaceuticals is relatively new to the type 1 diabetes space, and they are working hard to understand what it’s like for people to live with T1D so they can develop transformative therapies. They’re currently investigating and advancing cell therapies aimed at treating an underlying cause of type 1 – the absence of insulin-producing cells.
read more →
